Piotr J. Rudzki

Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?

Michał Kaza, Marta Karaźniewicz‐Łada, Katarzyna Kosicka et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 178 citations · Full text

Pharmacy, Pharmacokinetics, Analytical Toxicology +12

Determination of clopidogrel metabolite (SR26334) in human plasma by LC–MS

Hanna Ksycińska, Piotr J. Rudzki, Mirosława Bukowska-Kiliszek · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 68 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Quantitative evaluation of the matrix effect in bioanalytical methods based on LC–MS: A comparison of two approaches

Piotr J. Rudzki, Elżbieta Gniazdowska, Katarzyna Buś‐Kwaśnik · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 54 citations

Natural Sciences, Biochemistry, Chemistry +17

Cloud-point extraction is compatible with liquid chromatography coupled to electrospray ionization mass spectrometry for the determination of bisoprolol in human plasma

Joanna Giebułtowicz, Grzegorz Kojro, Katarzyna Buś‐Kwaśnik et al. · Journal of Chromatography A · 2015 · 29 citations

Natural Sciences, Chemistry, Pharmacology +17

Simplified LC–MS/MS method enabling the determination of azithromycin in human plasma after a low 100 mg dose administration

Monika Filist, Katarzyna Buś‐Kwaśnik, Hanna Ksycińska et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +12